Chronic brain inflammation leads to a decline in hippocampal NMDA-R1 receptors

[1]  M. Rogawski,et al.  The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. , 2006, CNS drug reviews.

[2]  P. Bickford,et al.  Sulindac improves memory and increases NMDA receptor subunits in aged Fischer 344 rats , 2004, Neurobiology of Aging.

[3]  G. Wenk,et al.  The toxicity of tumor necrosis factor-α upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: implications for alzheimer's disease , 2003, Neuroscience.

[4]  C L Galli,et al.  Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases , 2003, The Journal of Neuroscience.

[5]  B. Platt,et al.  Glutamate receptor function in learning and memory , 2003, Behavioural Brain Research.

[6]  Kiyoshi Morimoto,et al.  Acute Neuroinflammation Exacerbates Excitotoxicity in Rat Hippocampus in Vivo , 2002, Experimental Neurology.

[7]  T. Asada,et al.  Alterations of NMDAR1 and NMDAR2A/B immunoreactivity in the hippocampus after perforant pathway lesion , 2002, Neuropathology : official journal of the Japanese Society of Neuropathology.

[8]  H. Bi,et al.  N-methyl-d-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease , 2002, Journal of the Neurological Sciences.

[9]  B. Hauss-Wegrzyniak,et al.  Chronic Brain Inflammation Results in Cell Loss in the Entorhinal Cortex and Impaired LTP in Perforant Path-Granule Cell Synapses , 2002, Experimental Neurology.

[10]  A. Biegon,et al.  Region‐selective effects of neuroinflammation and antioxidant treatment on peripheral benzodiazepine receptors and NMDA receptors in the rat brain , 2002, Journal of neurochemistry.

[11]  Guy C. Brown,et al.  Inflammatory Neurodegeneration Mediated by Nitric Oxide from Activated Glia-Inhibiting Neuronal Respiration, Causing Glutamate Release and Excitotoxicity , 2001, The Journal of Neuroscience.

[12]  Roger N Gunn,et al.  In-vivo measurement of activated microglia in dementia , 2001, The Lancet.

[13]  A. Baskys,et al.  Neuroprotective effects of extracellular glutamate are absent in hippocampal organotypic cultures treated with the amyloid peptide Aβ25–35 , 2001, Brain Research.

[14]  G. Kollias,et al.  CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity , 2001, Nature Neuroscience.

[15]  Carol A. Barnes,et al.  Regional changes in the hippocampal density of AMPA and NMDA receptors across the lifespan of the rat , 2000, Brain Research.

[16]  Jean-Philippe Galons,et al.  Quantitative Volumetric Analyses of Brain Magnetic Resonance Imaging from Rat with Chronic Neuroinflammation , 2000, Experimental Neurology.

[17]  G. Wenk,et al.  Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons. , 2000, European journal of pharmacology.

[18]  G. Wenk,et al.  LPS‐induced neuroinflammatory effects do not recover with time , 2000, Neuroreport.

[19]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[20]  G. Wenk,et al.  Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats , 2000, Brain Research.

[21]  W. Liao,et al.  Inflammation in Alzheimer's Disease , 1999, Science.

[22]  G. Wenk,et al.  The effects of a novel NSAID on chronic neuroinflammation are age dependent☆ , 1999, Neurobiology of Aging.

[23]  P. Mcgeer,et al.  The importance of inflammatory mechanisms in alzheimer disease , 1998, Experimental Gerontology.

[24]  Tullio Pozzan,et al.  Prostaglandins stimulate calcium-dependent glutamate release in astrocytes , 1998, Nature.

[25]  P. Dobrzanski,et al.  Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease , 1998, Brain Research.

[26]  F. Morrell,et al.  Alzheimer’s Disease: In Vivo Detection of Differential Vulnerability of Brain Regions , 1997, Neurobiology of Aging.

[27]  J. Urenjak,et al.  Altered glutamatergic transmission in neurological disorders: From high extracellular glutamate to excessive synaptic efficacy , 1997, Progress in Neurobiology.

[28]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[29]  G. Levi,et al.  Induction of Prostanoid Biosynthesis by Bacterial Lipopolysaccharide and Isoproterenol in Rat Microglial Cultures , 1995, Journal of neurochemistry.

[30]  W. Fiers,et al.  Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Weiss,et al.  Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide , 1994, Journal of Neuroimmunology.

[32]  J. Buchhalter,et al.  Inhibition of Glutamate Uptake with l‐trans‐Pyrrolidine‐2,4‐Dicarboxylate Potentiates Glutamate Toxicity in Primary Hippocampal Cultures , 1993, Journal of neurochemistry.

[33]  J. Rothstein,et al.  Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Bert Sakmann,et al.  Heteromeric NMDA Receptors: Molecular and Functional Distinction of Subtypes , 1992, Science.

[35]  R. Albin,et al.  Alternative excitotoxic hypotheses , 1992, Neurology.

[36]  A. Arimura,et al.  Interleukin-1 beta increases prostaglandin E2 in rat astrocyte cultures: modulatory effect of neuropeptides. , 1989, Endocrinology.

[37]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[38]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[39]  G. Wenk,et al.  Chronic Intracerebral LPS as a Model of Neuroinflammation , 2003 .

[40]  P. Wood.  Neuroinflammation : mechanisms and management , 2003 .

[41]  T. Morgan,et al.  Inflammation in Alzheimer’s Disease , 2001 .